| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Nutrition Research Unit, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213
The knowledge of expression and biology of the intestinal oligopeptide transporter (Pept-1) in a metabolic disorder such as diabetes may have nutritional and pharmacological implications. To study this problem, rats were made diabetic by streptozotocin injection, and Western and Northern blot analyses and nuclear run-on assay were used to determine the protein and gene expressions of Pept-1 and its rate of transcription, respectively. Uncontrolled diabetes for 96 h increased the activity of Pept-1 in the brush-border membrane of intestinal mucosa. Studies of Michaelis-Menten constant, maximal velocity, and protein expression of Pept-1 indicated that an increase in the abundance of this transporter was responsible for the increased activity. Studies of the gene expression showed that uncontrolled diabetes increased the abundance of mRNA encoding Pept-1 without altering its rate of transcription. Lastly, studies of the specificity of the above effect showed that uncontrolled diabetes similarly affected the protein and gene expressions of Pept-1 located in the kidney. In conclusion, the data show that 1) uncontrolled diabetes has a tropic effect on Pept-1 and 2) the effect is systemic, and its molecular mechanism appears to be an increase in the stabilization of mRNA encoding Pept-1.
brush-border membrane; gene expression; gene transcription; intestinal transport; renal transport
This article has been cited by other articles:
|
|
 |
|
  M. Mertl, H. Daniel, and G. Kottra Substrate-induced changes in the density of peptide transporter PEPT1 expressed in Xenopus oocytes Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1332 - C1343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tramonti, P. Xie, E. I. Wallner, F. R. Danesh, and Y. S. Kanwar Expression and functional characteristics of tubular transporters: P-glycoprotein, PEPT1, and PEPT2 in renal mass reduction and diabetes. Am J Physiol Renal Physiol, November 1, 2006; 291(5): F972 - F980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Shimakura, T. Terada, H. Saito, T. Katsura, and K.-i. Inui Induction of intestinal peptide transporter 1 expression during fasting is mediated via peroxisome proliferator-activated receptor {alpha} Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G851 - G856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Shimakura, T. Terada, T. Katsura, and K.-I. Inui Characterization of the human peptide transporter PEPT1 promoter: Sp1 functions as a basal transcriptional regulator of human PEPT1 Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G471 - G477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shimizu, S. Masuda, K. Nishihara, L. Ji, M. Okuda, and K.-i. Inui Increased protein level of PEPT1 intestinal H+-peptide cotransporter upregulates absorption of glycylsarcosine and ceftibuten in 5/6 nephrectomized rats Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G664 - G670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Adibi Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G779 - G788. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
